Vitamin E: Tocopherols and tocotrienols as potential radiation countermeasures

Journal of Radiation Research

Volumn 54, Issue 6, 2013, Pages 973-988

  Singh, Vijay K ^a,b   Beattie, Lindsay A ^a   Seed, Thomas M ^c  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Tech Micro Services   (United States)

Author keywords

Countermeasures; Mice; Radiation; Tocopherols; Tocotrienols; Vitamin E

Indexed keywords

ANTIOXIDANTS; FREE RADICALS;

COUNTERMEASURE; GRANULOCYTE-COLONY STIMULATING FACTOR; HEALTH CONSEQUENCES; MOUSE; RADIATION EXPOSURE; RADIOPROTECTIVE EFFICACY; TOCOPHEROL; TOCOTRIENOLS; TOTAL BODY IRRADIATION; VITAMIN-E;

RADIATION;

ANIMALIA; MUS; PRIMATES; RODENTIA;

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; RADIOPROTECTIVE AGENT; TOCOPHEROL;

ACUTE RADIATION SYNDROME; ANIMAL; COUNTERMEASURES; HUMAN; INTENSIVE CARE; METHODOLOGY; MOUSE; PATHOPHYSIOLOGY; RADIATION; RADIATION PROTECTION; REVIEW; TREATMENT OUTCOME;

COUNTERMEASURES; MICE; RADIATION; TOCOPHEROLS; TOCOTRIENOLS; VITAMIN E;

ACUTE RADIATION SYNDROME; ANIMALS; CRITICAL CARE; HUMANS; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; TOCOPHEROLS; TOCOTRIENOLS; TREATMENT OUTCOME; VITAMIN E;

EID: 84888245393     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt048     Document Type: Review

References (126)

1. Singh VK, Seed TM. Radiation effects. In: Roy MJ (ed). Physician's Guide to Terrorist Attack. Totowa: Humana Press, 2003, 339-62
2. Carter AB, May MM, Perry WJ. The day after: action following a nuclear blast in a U.S. city. Washington Quarterly 2007;30:19-32
3. Benjamin GC, McGeary M, McCutchen SR. Assessing Medical Preparedness to Respond to a Terrorist Nuclear Event: Workshop Report. Washington, DC: The National Academies Press, 2009
4. Hall EJ, Giaccia AJ. Radiobiology for the Radiobiologist. Philadelphia, PA: LippincottWilliams andWilkins, 2006
5. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol 2002;30:513-28
6. Gusev IA, Guskova AK, Mettler FA. Medical Management of Radiation Accidents. Boca Raton, FL: CRC Press, 2001
7. Glasstone S, Dolan PJ. The Effects of Nuclear Weapons. Washington, DC: Department of Army, Headquarters, 1977
8. Singh VK, Ducey EJ, Brown DS et al. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol 2012; 88:296-310
9. Weiss JF, Landauer MR. History and development of radiation-protective agents. Int J Radiat Biol 2009;85:539-73
10. Dumont F, Le Roux A, Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Pat 2010;20:73-101
11. Agarwal SS, Singh VK. Immunomodulators: a review of studies on Indian medicinal plants and synthetic peptides. Part I: Medicinal plants. Proc Ind Nat Sci Acad B 1999;65:179-204
12. Papas A. The Vitamin Factor. New York, NY: Harper Perennial, Harper-Collins Publishers Inc., 1999
13. Nesaretnam K. Multitargeted therapy of cancer by tocotrienols. Cancer Lett 2008;269:388-95
14. Traber MG, Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr 1995;62:1501-9S
15. Traber MG, Sies H. Vitamin E in humans: demand and delivery. Annu Rev Nutr 1996;16:321-47
16. Papas A. Vitamin E: tocopherols and tocotrienols. In: Papas AM (ed). Antioxidant Status, Diet, Nutrition, and Health. Boca Raton: CRC Press, 1999, 189-210
17. Palozza P, Simone R, Picci N et al. Design, synthesis, and antioxidant potency of novel alpha-tocopherol analogues in isolated membranes and intact cells. Free Radic Biol Med 2008;44:1452-64
18. Palozza P, Verdecchia S, Avanzi L et al. Comparative antioxidant activity of tocotrienols and the novel chromanylpolyisoprenyl molecule FeAox-6 in isolated membranes and intact cells. Mol Cell Biochem 2006;287:21-32
19. Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci 2006;78:2088-98
20. Aggarwal BB, Sundaram C, Prasad S et al. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 2010;80: 1613-31
21. Sen CK, Khanna S, Roy S et al. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60 (c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 2000;275:13049-55
22. Luk SU, Yap WN, Chiu YT et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer 2011;128:2182-91
23. Hussein D, Mo H. d-delta-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 2009;38: e124-36
24. Pearce BC, Parker RA, Deason ME et al. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 1992;35:3595-606
25. Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann N Y Acad Sci 2000;899:44-60
26. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003;189:1-20
27. Singh PK, Wise SY, Ducey EJ et al. Alpha-tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res 2012;177:133-45
28. Ghosh SP, Kulkarni S, Hieber K et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol 2009;85:598-606
29. Li XH, Fu D, Latif NH et al. Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signaling. Haematologica 2010;95: 1996-2004
30. Satyamitra M, Kulkarni S, Ghosh SP et al. Hematopoietic recovey and amelioration of radiation-induced lethality by the vitamin E isoform, delta-tocotrienol. Radiat Res 2011;175: 736-45
31. Birringer M, Pfluger P, Kluth D et al. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr 2002;132:3113-8
32. Das S, Das M, Das DK. Vitamin E isomers, tocotrienols, in cardioprotection. In: Wartson RR, Preedy VR (eds). Tocotrienols: Vitamins Beyond Tocopherols. Boca Raton: CRC Press, 2009, 285-93
33. Khanna S, Roy S, Slivka A et al. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005;36: 2258-64
34. Miyazawa T, Tsuzuki T, Nakagawa K et al. Antiangiogenic potency of vitamin E. Ann N Y Acad Sci 2004;1031:401-4
35. Qureshi AA, Sami SA, Salser WA et al. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 2001;12:318-29
36. Qureshi AA, Sami SA, Salser WA et al. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002;161:199-207
37. Qureshi AA, Peterson DM, Hasler-Rapacz JO et al. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 2001;131:223-30
38. Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996;31:671-701
39. Pearce BC, Parker RA, Deason ME et al. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J Med Chem 1994;37:526-41
40. Serbinova E, Kagan V, Han D et al. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 1991;10:263-75
41. Serbinova EA, Packer L. Antioxidant properties of alphatocopherol and alpha-tocotrienol. Methods Enzymol 1994; 234:354-66
42. Muller L, Theile K, Bohm V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res 2010;54:731-42
43. Khor HT, Ng TT. Effects of administration of alphatocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity. Int J Food Sci Nutr 2000;51 Suppl: S3-11
44. Qureshi AA, Pearce BC, Nor RM et al. Dietary alphatocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr 1996;126:389-94
45. Parker RA, Pearce BC, Clark RW et al. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1993;268:11230-8
46. Song BL, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem 2006;281:25054-61
47. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-30
48. Saito Y, Yoshida Y, Nishio K et al. Characterization of cellular uptake and distribution of vitamin E. Ann N Y Acad Sci 2004;1031:368-75
49. Tsuzuki W, Yunoki R, Yoshimura H. Intestinal epithelial cells absorb gamma-tocotrienol faster than alpha-tocopherol. Lipids 2007;42:163-70
50. Stone HB, Moulder JE, Coleman CN et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28
51. Seed TM. Radiation protectants: current status and future prospects. Health Phys 2005;89:531-45
52. Singh VK, Brown DS, Kao TC. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 2009;9:1423-30
53. Berbee M, Hauer-Jensen M. Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory? Curr Opin Support Palliat Care 2012;6:54-59
54. Kumar KS, Srinivasan V, Toles R et al. Nutritional approaches to radioprotection: vitamin E. Mil Med 2002;167: 57-9
55. Yuhas JM, Storer JB. Chemoprotection against three modes of radiation death in the mouse. Int J Radiat Biol Relat Stud Phys Chem Med 1969;15:233-7
56. Brown DQ, Graham WJ, III, MacKenzie LJ et al. Can WR-2721 be improved upon? Pharmacol Ther 1988;39: 157-68
57. Nightengale SL, Prasher JM, Simonson S. Emergency use authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis 2002;7:1046-55
58. U.S. Food and Drug Administration. Guidance for Industry, Animal Models - Essential Elements to Address Efficacy under the Animal Rule. Silver Spring, MD: CBER, 2009
59. Boerma M, Roberto KA, Hauer-Jensen M. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 2008;72:170-7
60. Empey LR, Papp JD, Jewell LD et al. Mucosal protective effects of vitamin E and misoprostol during acute radiationinduced enteritis in rats. Dig Dis Sci 1992;37:205-14
61. Konings AW, Damen J, Trieling WB. Protection of liposomal lipids against radiation induced oxidative damage. Int J Radiat Biol Relat Stud Phys Chem Med 1979;35:343-50
62. Malick MA, Roy RM, Sternberg J. Effect of vitamin E on post irradiation death in mice. Experientia 1978;34:1216-7
63. Roy RM, Petrella M, Shateri H. Effects of administering tocopherol after irradiation on survival and proliferation of murine lymphocytes. Pharmacol Ther 1988;39:393-5
64. Sarma L, Kesavan PC. Protective effects of vitamins C and E against gamma-ray-induced chromosomal damage in mouse. Int J Radiat Biol 1993;63:759-64
65. Srinivasan V, Jacobs AJ, Simpson SA et al. Radioprotection by vitamin E: effects on hepatic enzymes, delayed type hypersensitivity and postirradiation survival of mice. In: Meyskens FL, Jr, Prasad KN (eds). Modulation and Mediation of Cancer by Vitamins. Basel: Karger, 1983, 119-31
66. Srinivasan V, Weiss JF. Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice. Int J Radiat Oncol Biol Phys 1992;23:841-5
67. Bichay TJ, Roy RM. Modification of survival and hematopoiesis in mice by tocopherol injection following irradiation. Strahlenther Onkol 1986;162:391-9
68. Seed T, Kumar S, Whitnall M et al. New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel. J Radiat Res (Tokyo) 2002;43 Suppl:S239-44
69. Singh VK, Shafran RL, Jackson WE, III et al. Induction of cytokines by radioprotective tocopherol analogs. Exp Mol Pathol 2006;81:55-61
70. Murase H, Yamauchi R, Kato K et al. Synthesis of a novel vitamin E derivative, 2-(alpha-D-glucopyranosyl) methyl- 2,5,7,8-tetramethylchroman-6-ol, by alpha-glucosidase-catalyzed transglycosylation. Lipids 1997;32:73-8
71. Murase H, Moon JH, Yamauchi R et al. Antioxidant activity of a novel vitamin E derivative, 2-(alpha-D glucopyranosyl) methyl-2,5,7,8- tetramethylchroman-6-ol. Free Radic Biol Med 1998;24:217-25
72. Nair CK, Devi PU, Shimanskaya R et al. Water soluble vitamin E (TMG) as a radioprotector. Indian J Exp Biol 2003;41:1365-71
73. Satyamitra M, Devi PU, Murase H et al. In vivo radioprotection by alpha-TMG: preliminary studies. Mutat Res 2001;479:53-61
74. Satyamitra M, Uma Devi P, Murase H et al. In vivo postirradiation protection by a vitamin E analog, alpha-TMG. Radiat Res 2003;160:655-61
75. Cherdyntseva N, Shishkina A, Butorin I et al. Effect of tocopherol- monoglucoside (TMG), a water-soluble glycosylated derivate of vitamin E, on hematopoietic recovery in irradiated mice. J Radiat Res (Tokyo) 2005;46:37-41
76. Ueno M, Inano H, Onoda M et al. Modification of mortality and tumorigenesis by tocopherol-mono-glucoside (TMG) administered after X irradiation in mice and rats. Radiat Res 2009;172:519-24
77. Rajagopalan R, Wani K, Huilgol NG et al. Inhibition of gamma-radiation induced DNA damage in plasmid pBR322 by TMG, a water-soluble derivative of vitamin E. J Radiat Res (Tokyo) 2002;43:153-9
78. Kapoor S, Mukherjee T, Kagiya TV et al. Redox reactions of tocopherol monoglucoside in aqueous solutions: a pulse radiolysis study. J Radiat Res (Tokyo) 2002;43:99-106
79. Nair CK, Salvi V, Kagiya TV et al. Relevance of radioprotectors in radiotherapy: studies with tocopherol monoglucoside. J Environ Pathol Toxicol Oncol 2004;23:153-60
80. Kumar B, Jha MN, Cole WC et al. D-alpha-tocopheryl succinate (vitamin E) enhances radiation-induced chromosomal damage levels in human cancer cells, but reduces it in normal cells. J Am Coll Nutr 2002;21:339-43
81. Neuzil J, Svensson I, Weber T et al. Alpha-tocopheryl succinate- induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 1999;445:295-300
82. Neuzil J, Weber T, Schroder A et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 2001;15:403-15
83. Neuzil J, Zhao M, Ostermann G et al. Alpha-tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability. Biochem J 2002;362:709-15
84. Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer 2003;89:1822-6
85. Kang YH, Lee E, Choi MK et al. Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer 2004;112:385-92
86. Prasad KN, Kumar B, Yan XD et al. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J Am Coll Nutr 2003;22:108-17
87. Shanker M, Gopalan B, Patel S et al. Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways. Cancer Lett 2007;254:217-26
88. Wang XF, Dong L, Zhao Y et al. Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate. Mol Nutr Food Res 2006;50:675-85
89. Singh VK, Parekh VI, Brown DS et al. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys 2011;79:571-8
90. Singh VK, Singh PK, Wise SY et al. Radioprotective properties of tocopherol succinate against ionizing radiation in mice. J Radiat Res 2013;54:210-20
91. Singh PK, Wise SY, Ducey EJ et al. Radioprotective efficacy of tocopherol succinate is mediated through granulocytecolony stimulating factor. Cytokine 2011;56:411-21
92. Singh VK, Brown DS, Kao TC. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte- colony stimulating factor. Int J Radiat Biol 2010;86: 12-21
93. Patchen ML, MacVittie TJ, Solberg BD et al. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor. Exp Hematol 1990;18:1042-8
94. MacVittie TJ, Monroy RL, Patchen ML et al. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 1990;57:723-36
95. Tanikawa S, Nose M, Aoki Y et al. Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice. Blood 1990;76:445-9
96. Schuening FG, Storb R, Goehle S et al. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 1989;74: 1308-13
97. Farese AM, Cohen MV, Katz BP et al. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res 2013;179:89-100
98. Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22
99. Singh VK, Singh PK, Wise SY et al. Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches. Int Immunopharmacol 2011;11:842-47
100. Singh VK, Brown DS, Kao TC et al. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol 2010;38:61-70
101. Singh VK, Wise SY, Singh PK et al. Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation- induced gastrointestinal injury in mice. Exp Hematol 2012;40:407-17
102. Singh VK, Wise SY, Singh PK et al. Alpha-tocopherol succinate- mobilized progenitors improve intestinal integrity after whole body irradiation. Int J Radiat Biol 2013;doi: 10.3109/ 09553002.2013.762137, Epub ahead of print
103. Sen CK, Khanna S, Rink C et al. Tocotrienols: the emerging face of natural vitamin E. Vitam Horm 2007;76:203-61
104. Sen CK, Khanna S, Roy S. Tocotrienol: the natural vitamin E to defend the nervous system? Ann N Y Acad Sci 2004;1031:127-42
105. Satyamitra M, Ney P, Graves J, III et al. Mechanism of radioprotection by delta-tocotrienol: pharmacokinetics, pharmacodynamics and modulation of signalling pathways. Br J Radiol 2012;85:e1093-103
106. Qureshi AA, Burger WC, Peterson DM et al. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 1986;261:10544-50
107. Baliarsingh S, Beg ZH, Ahmad J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005;182:367-74
108. Kulkarni S, Ghosh SP, Satyamitra M et al. Gamma-tocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation. Radiat Res 2010;173:738-47
109. Kulkarni SS, Cary LH, Gambles K et al. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. Int Immunopharmacol 2012;14:495-503
110. Grace MB, Singh VK, Rhee JG et al. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res 2012;53:840-53
111. Krivokrysenko VI, Shakhov AN, Singh VK et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J Pharmacol Exp Ther 2012;343:497-508
112. Singh VK, Fatanmi OO, Singh PK et al. Role of radiationinduced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine 2012;58: 406-14
113. Kulkarni S, Singh PK, Ghosh S et al. Granulocyte-colony stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure. Cytokine 2013;doi: 10.1016/j.cyto.2013.03. 009, Epub ahead of print
114. Ray S, Kulkarni SS, Chakraborty K et al. Mobilization of progenitor cells into peripheral blood by gamma-tocotrienol: a promising radiation countermeasure. Int Immunopharmacol 2013;15:557-64
115. Berbee M, Fu Q, Boerma M et al. Gamma-tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiat Res 2009;171: 596-605
116. Berbee M, Fu Q, Boerma M et al. Reduction of radiationinduced vascular nitrosative stress by the vitamin E analog gamma-tocotrienol: evidence of a role for tetrahydrobiopterin. Int J Radiat Oncol Biol Phys 2011;79:884-91
117. Delanian S, Porcher R, Balla-Mekias S et al. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003;21:2545-50
118. Delanian S, Porcher R, Rudant J et al. Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 2005;23:8570-9
119. Hille A, Christiansen H, Pradier O et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 2005;181:606-14
120. Misirlioglu CH, Demirkasimoglu T, Kucukplakci B et al. Pentoxifylline and alpha-tocopherol in prevention of radiation- induced lung toxicity in patients with lung cancer. Med Oncol 2007;24:308-11
121. Berbee M, Fu Q, Garg S et al. Pentoxifylline enhances the radioprotective properties of gamma-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems. Radiat Res 2011;175:297-306
122. Bacq ZM. The amines and particularly cysteamine as protectors against roentgen rays. Acta Radiol 1954;41:47-55
123. Citrin D, Cotrim AP, Hyodo F et al. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010;15:360-71
124. Landauer MR, Davis HD, Kumar KS et al. Behavioral toxicity of selected radioprotectors. Adv Space Res 1992;12:273-83
125. Lippman SM, Klein EA, Goodman PJ et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51
126. Lonn E, Bosch J, Yusuf S et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47